Navigation Links
Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP

ormation on trials please visit http://www.itpstudy.com or http://www.clinicaltrials.gov.

Notes to Editors

PROMACTA(R) is the proposed registered trademark of the GlaxoSmithKline group of companies to be used in the United States.

    To access the latest GSK news, visit http://us.gsk.com/.



    US Media enquiries:              Jeff McLaughlin    1 919 483 2839


                                     Mary Anne Rhyne    1 919 483 2839



    US Analyst/ Investor             Frank Murdolo      1 215 751 7002

    enquiries:

                                     Tom Curry          1 215 751 5419



    REFERENCES


    (1)  Bussel, J., Provan A., Shamsi T et al. Eltrombopag Raises Platelet

         Count and Reduces Bleeding compared with Placebo during

         Short-term Treatment in Chronic Idiopathic Thrombocytopenic Purpura:

         A Phase III Study. Presented 9th June 2007, 12th Congress of the

         European Hematology Association, Vienna, Austria.

    (2)  Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic

         purpura. Annu Rev Med. 2005;56:425-442.

    (3)  Cohen, YC., Djulbegovic B., et al.  The bleeding risk and natural

         history of idiopathic thrombocytopenic purpura in patients with

         persistent low platelet counts. Arch Int Med. 2000:160 (11);1630-8.

    (4)  Bussel, J., Cheng, G. et al.  Analysis of Bleeding in Patients with

         Immune Thrombocytopenic Purpura (ITP): A Randomized, Double-Blind,

         Placebo-Controlled Trial of Eltrombopag, an Oral Platelet Growth

         Factor. Presented 11 December 2006, 48th Annual Meeting of the

         American Society of Hematology, Orlando, Florida, USA -

         - Abstract #475.

    (5)  htt
'"/>





Page: 1 2 3 4 5 6

Related medicine technology :

1. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
2. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
5. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
6. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
7. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
9. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
10. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
11. GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO
Post Your Comments:
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/14/2014)... Jan. 14, 2014 HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... it expects revenues for the fourth quarter of 2013 ... revenues to approximately $208 million. "Our full-year ...
(Date:1/14/2014)... The Brandeis Medical Center, led by Dr. Emmanuel Brandeis ... affordable laser tattoo removal experience with the advanced Astanza Duality laser ... high quality cosmetic services with cutting edge medical technology and offering ... California has seen a dramatic increase in the presence ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... Aug. 17 In response to unprecedented devastation and human ... Foundations today announced it would give an additional $5 million ... "We need everyone to pitch in to the ... Open Society Foundation in Pakistan – FOSI-Pakistan. "While the government ...
... FEICHENG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- ... ... var shortURL ... by longUrl, so we need to grab the first one. for (var r in data.results) { ...
Cached Medicine Technology:George Soros to Boost Civil Society Response in Flood Affected Areas of Pakistan 2China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 2China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 3China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 4China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 5China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 6China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 7China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 8China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 9China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 10China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 11China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 12China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 13China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 14China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010 15
(Date:4/23/2014)... could help doctors predict which patients might suffer potentially ... The program, which assesses brain scans using pattern recognition ... passport control, has been developed by researchers at Imperial ... the Wellcome Trust, which used the software are published ... Stroke affects over 15 million people each year worldwide. ...
(Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
(Date:4/23/2014)... vegetables are often displayed in the popular Swedish ... plenty of high-sugar foods. A new study from ... portrayed in children,s TV programmes as well as ... habits and weight status. , Steingerdur Olafsdottir,s doctoral ... the popular Swedish children,s TV show Bolibompa. Healthy ...
(Date:4/23/2014)... Five for-profit and non-profit organizations in Washington ... Proof of Concept grants to accelerate maturation of ... the Life Sciences Discovery Fund (LSDF) announced today. ... grant to the Washington Biotechnology & Biomedical Association ... train the next generation of entrepreneurs and help ...
(Date:4/23/2014)... physicians concerned about an increase in adolescents, marijuana use ... sigh of relief. According to a new study at ... data from states with and without medical marijuana laws, ... among adolescents. The study is published online in advance ... . , "Any time a state considers legalizing ...
Breaking Medicine News(10 mins):Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2
... , , , MORRISTOWN, ... WPI ), a leader in generic and specialty branded ... Company as Executive Vice President, Global Brands. In this ... aspects of the Company,s global brand pharmaceutical business, including brand ...
... BALTIMORE, Sept. 21 A new survey from ... is contributing to acute, or short-term, physical pain for Americans. ... Month, 68 percent of people who experienced acute back pain ... year said that the recession caused, increased or affected their ...
... , , BIRMINGHAM, Ala., Sept. 21 ... that it has received a request for proposal (RFP) from the ... of intravenous (i.v) peramivir for the treatment of critically ill influenza ... The RFP indicates that the minimum and maximum order ...
... , , INDIANAPOLIS, Sept. 21 ... nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received ... as compared to placebo plus best supportive care. , ... studies looking at the use of histology to tailor treatment with ...
... DETROIT, Sept. 21 Webahn, Inc. announces the launch of ... Electronic Medical Records service Capzule.com and Accent, a voice recording ... , Capzule enables physicians to access patient information ... capability to send messages, add notes, prescribe medications and write ...
... is a serious condition that involves the formation of a ... legs. A patient with DVT is typically treated with anticoagulants ... procedures may play a more central role in the long-term ... October issue of the American Journal of Roentgenology ...
Cached Medicine News:Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 2Health News:Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands 3Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 2Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 3Health News:Economic Pain Contributing to Acute Physical Pain for Many Americans, New Survey Says 4Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 2Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 3Health News:BioCryst Receives Peramivir Request for Proposal From the U.S. Government 4Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 2Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 3Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 4Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 5Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 6Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 7Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 8Health News:Voice, Medical Records iPhone Apps Launched for Physicians 2Health News:Image-guided treatment for deep venous thrombosis could improve patients' long-term outcomes 2
... Available in small and large sizes, ... popular, easy-to-place, silver/silver chloride disposable tabs. For ... 17). Dimensions (contact surface): large tabs-2.2 x ... tabs-1.5 cm (0.5 in) square. Each 100-count ...
... Symphony orchestrates images and patient information ... information sources in one central system. ... and improves cost-effectiveness so that healthcare ... do best, helping people., ,Many Sources, ...
... Maxenon Xi300 is so bright many surgeons turn ... gears to shift into when the going gets ... as a true Hot Start and the technologically ... system that prevent failed start ups and overheating. ...
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
Medicine Products: